Trial Profile
Neoadjuvant Chemotherapy for HER2-positive Stage IV advanced gastric cancer with S-1/Cisplatin/Trastuzumab
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin; Trastuzumab
- Indications Gastric cancer
- Focus Adverse reactions
- 10 May 2011 New trial record